Cancer Network Podcasts
Bevacizumab Plus Chemotherapy in Patients With Early Stage HER2-Negative Breast Cancer
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:10:45
- Mas informaciones
Informações:
Sinopsis
Dr. Gunter von Minckwitz discusses the recent paper he authored that showed that bevacizumab in addition to neoadjuvant chemotherapy significantly increased the rate of pathological complete response in patients with early stage HER2-negative breast cancer.
